Search results
Semaglutide could offer an easier and more reliable way to lose weight and combat the health impacts people with obesity face. Why should this drug, proven to work, not be available to help people change their lives?
3 sie 2023 · Semaglutide is an injectable drug formulated for the treatment of type 2 diabetes, but it’s since become increasingly popular as a weight loss treatment.
13 maj 2024 · Here in this prespecified analysis, we examined effects of semaglutide on weight and anthropometric outcomes, safety and tolerability by baseline body mass index (BMI). In patients treated with...
Semaglutide has been shown to increase energy expenditure and promote fat burning, leading to reductions in body weight and improvements in body composition. It may also have a positive impact on lipid metabolism, contributing to favorable changes in cholesterol and triglyceride levels.
1 cze 2024 · The anti-inflammatory effects of semaglutide have been shown to provide cardiovascular benefits in several experiments [62]. Semaglutide has been found to protect endothelial progenitor cells by inhibiting the expression of miR-155 (a microRNA) in macrophage exosomes [62].
19 lip 2024 · The drug, generically called semaglutide, is modeled after an unassuming gut hormone called glucagonlike peptide 1 (GLP-1), which stimulates insulin production—as well as the feeling of satiety,...
23 cze 2024 · Semaglutide is found to be efficient for weight loss in patients with overweight or obesity with diabetes mellitus (DM). With a wide range of adverse events reported, the efficacy and safety of once-weekly subcutaneous semaglutide in individuals without DM, with overweight or obesity, is unclear.
